Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | REGISTRATION STATEMENT | fs42021a1_cmlifesci3.htm iXBRL | S-4/A | 14897085 |
2 | OCTOBER 1, 2021 | fs42021a1ex8-1_cmlifesci3.htm | EX-8.1 | 9428 |
3 | OPINION OF GOODWIN PROCTER LLP AS TO CERTAIN U.S. FEDERAL TAX MATTERS | fs42021a1ex8-2_cmlifesci3.htm | EX-8.2 | 11632 |
4 | INCENTIVE STOCK OPTION GRANT NOTICE | fs42021a1ex10-4_cmlifesci3.htm | EX-10.4 | 257206 |
5 | FORM OF NON-EMPLOYEE DIRECTOR COMPENSATION POLICY | fs42021a1ex10-5_cmlifesci3.htm | EX-10.5 | 20317 |
6 | SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN | fs42021a1ex10-6_cmlifesci3.htm | EX-10.6 | 19279 |
7 | SEVERANCE AND CHANGE IN CONTROL POLICY | fs42021a1ex10-7_cmlifesci3.htm | EX-10.7 | 30593 |
8 | AMENDED AND RESTATED EMPLOYMENT LETTER AGREEMENT | fs42021a1ex10-8_cmlifesci3.htm | EX-10.8 | 103567 |
9 | EMPLOYMENT LETTER AGREEMENT | fs42021a1ex10-9_cmlifesci3.htm | EX-10.9 | 40653 |
10 | ERIC HEDRICK, M.D | fs42021a1ex10-10_cmlifesci3.htm | EX-10.10 | 18551 |
11 | AMENDED AND RESTATED EMPLOYMENT LETTER AGREEMENT | fs42021a1ex10-12_cmlifesci3.htm | EX-10.12 | 97603 |
12 | FOUNDER AGREEMENT | fs42021a1ex10-13_cmlifesci3.htm | EX-10.13 | 56984 |
13 | FORM OF DIRECTOR INDEMNIFICATION AGREEMENT | fs42021a1ex10-14_cmlifesci3.htm | EX-10.14 | 84566 |
14 | FORM OF OFFICER INDEMNIFICATION AGREEMENT | fs42021a1ex10-15_cmlifesci3.htm | EX-10.15 | 76942 |
15 | LEASE AGREEMENT | fs42021a1ex10-16_cmlifesci3.htm | EX-10.16 | 504295 |
16 | SUBLEASE AGREEMENT | fs42021a1ex10-17_cmlifesci3.htm | EX-10.17 | 96485 |
17 | EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN CSTONE PHARMACEUTICALS AND EQRX, IN | fs42021a1ex10-18_cmlifesci3.htm | EX-10.18 | 425499 |
18 | STRATEGIC COLLABORATION AND LICENSE AGREEMENT | fs42021a1ex10-19_cmlifesci3.htm | EX-10.19 | 306440 |
19 | CONSENT OF WITHUMSMITH+BROWN, PC | fs42021a1ex23-1_cmlifesci3.htm | EX-23.1 | 1599 |
20 | CONSENT OF ERNST & YOUNG LLP | fs42021a1ex23-2_cmlifesci3.htm | EX-23.2 | 2899 |
21 | CONSENT TO REFERENCE IN PROXY STATEMENT/PROSPECTUS | fs42021a1ex99-10_cmlifesci3.htm | EX-99.10 | 3401 |
22 | CONSENT OF HOULIHAN LOUKEY CAPITAL, INC. | fs42021a1ex99-11_cmlifesci3.htm | EX-99.11 | 6616 |
28 | GRAPHIC | ex8-1_001.jpg | GRAPHIC | 9214 |
29 | GRAPHIC | ex8-2_001.jpg | GRAPHIC | 7219 |
30 | GRAPHIC | ex10-9_001.jpg | GRAPHIC | 4402 |
31 | GRAPHIC | ex10-10_001.jpg | GRAPHIC | 6313 |
32 | GRAPHIC | ex10-16_001.jpg | GRAPHIC | 44382 |
33 | GRAPHIC | ex10-16_002.jpg | GRAPHIC | 44846 |
34 | GRAPHIC | ex10-16_003.jpg | GRAPHIC | 40098 |
35 | GRAPHIC | ex10-16_004.jpg | GRAPHIC | 38837 |
36 | GRAPHIC | ex10-16_005.jpg | GRAPHIC | 38926 |
37 | GRAPHIC | ex10-16_006.jpg | GRAPHIC | 31157 |
38 | GRAPHIC | ex10-16_007.jpg | GRAPHIC | 30977 |
39 | GRAPHIC | ex10-16_008.jpg | GRAPHIC | 31563 |
40 | GRAPHIC | ex10-16_009.jpg | GRAPHIC | 88509 |
41 | GRAPHIC | ex10-16_010.jpg | GRAPHIC | 33184 |
42 | GRAPHIC | ex10-16_011.jpg | GRAPHIC | 49784 |
43 | GRAPHIC | ex10-18_001.jpg | GRAPHIC | 4297 |
44 | GRAPHIC | ex10-18_002.jpg | GRAPHIC | 2668 |
45 | GRAPHIC | teqrx_logo.jpg | GRAPHIC | 702720 |
46 | GRAPHIC | teqrxstand_001.jpg | GRAPHIC | 1004746 |
47 | GRAPHIC | tmission_001.jpg | GRAPHIC | 1420356 |
48 | GRAPHIC | tglance_001.jpg | GRAPHIC | 1484773 |
49 | GRAPHIC | tletter_001.jpg | GRAPHIC | 197583 |
50 | GRAPHIC | timage_001.jpg | GRAPHIC | 394753 |
51 | GRAPHIC | timage_002.jpg | GRAPHIC | 605466 |
52 | GRAPHIC | timage_003.jpg | GRAPHIC | 585535 |
53 | GRAPHIC | timage_004.jpg | GRAPHIC | 503201 |
54 | GRAPHIC | timage_005.jpg | GRAPHIC | 2184803 |
55 | GRAPHIC | timage_006.jpg | GRAPHIC | 518500 |
56 | GRAPHIC | timage_007.jpg | GRAPHIC | 452546 |
57 | GRAPHIC | timage_008.jpg | GRAPHIC | 597911 |
58 | GRAPHIC | timage_009.jpg | GRAPHIC | 451289 |
59 | GRAPHIC | timage_010.jpg | GRAPHIC | 629346 |
60 | GRAPHIC | timage_011.jpg | GRAPHIC | 600409 |
61 | GRAPHIC | timage_012.jpg | GRAPHIC | 593799 |
62 | GRAPHIC | teqrx_logored.jpg | GRAPHIC | 706221 |
63 | GRAPHIC | teqrx_red.jpg | GRAPHIC | 679639 |
Complete submission text file | 0001213900-21-051237.txt | 64872132 |
Data Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
23 | XBRL SCHEMA FILE | cmlt-20210630.xsd | EX-101.SCH | 148586 |
24 | XBRL CALCULATION FILE | cmlt-20210630_cal.xml | EX-101.CAL | 37439 |
25 | XBRL DEFINITION FILE | cmlt-20210630_def.xml | EX-101.DEF | 658946 |
26 | XBRL LABEL FILE | cmlt-20210630_lab.xml | EX-101.LAB | 913296 |
27 | XBRL PRESENTATION FILE | cmlt-20210630_pre.xml | EX-101.PRE | 644260 |
64 | EXTRACTED XBRL INSTANCE DOCUMENT | fs42021a1_cmlifesci3_htm.xml | XML | 3777997 |
IRS No.: 861691173 | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-259054 | Film No.: 211300859
SIC: 2834 Pharmaceutical Preparations